跳到正文
原文
Endpoints News 生物医药· Ayisha Sharma·· 14 天前AI 评分31

Immunocore 报告 brenetafusp 联合 Kimmtrak 治疗 uveal 熊猫瘤早期数据

#SITC26: Immunocore reports early data for brenetafusp plus Kimmtrak in uveal melanoma

AI 导读

Immunocore 报告,约 70% 的 uveal 熊猫瘤患者在使用 brenetafusp 联合 Kimmtrak 治疗时表现出积极反应。

正文

In an ear­ly test of two bis­pe­cif­ic T cell en­gagers com­bined in a sol­id tu­mor, Im­muno­core said an es­ti­mat­ed 70% of cer­tain uveal melanoma pa­tients …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news